E-Mail BUFFALO, N.Y. - The University at Buffalo has received a $1.5 million grant from the United States Department of Defense to develop new therapies that help reduce chronic inflammation and immunosuppression in oral cancers. Through the three-year grant, the research will center on a type of white blood cell called a macrophage that - after migrating to oral tumors - triggers uncontrolled inflammation, which suppresses the body's immune response and lowers the effectiveness of anticancer therapies. The researchers aim to reprogram the macrophages by targeting genes that regulate inflam...